These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2068159)

  • 1. Antisense suppression of N-myc expression inhibits the transdifferentiation of neuroectoderm tumor cell lines.
    Whitesell L; Rosolen A; Neckers LM
    Prog Clin Biol Res; 1991; 366():45-54. PubMed ID: 2068159
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense inhibition of CHP100 C-myc expression results in reduced in vitro growth kinetics and loss of in vivo tumorigenesis.
    Rosolen A; Toretsky J; Neckers L
    Prog Clin Biol Res; 1994; 385():95-101. PubMed ID: 7972241
    [No Abstract]   [Full Text] [Related]  

  • 3. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
    Chen J; Chattopadhyay B; Venkatakrishnan G; Ross AH
    Cell Growth Differ; 1990 Feb; 1(2):79-85. PubMed ID: 1964795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
    Chen J; Liu T; Zhe X; Jiang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA; Lazarova DL; Ross RA; Biedler JL
    Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system.
    Rouah E; Wilson DR; Armstrong DL; Darlington GJ
    Cancer Res; 1989 Apr; 49(7):1797-801. PubMed ID: 2924321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
    Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
    J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
    Sleight BJ; Soukup S; Ballard ET; Parysek LM
    Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry.
    Gazitt Y; He YJ; Chang L; Koza S; Fisk D; Graham-Pole J
    Cancer Res; 1992 May; 52(10):2957-65. PubMed ID: 1374683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
    Rosolen A; Whitesell L; Ikegaki N; Kennett RH; Neckers LM
    Cancer Res; 1990 Oct; 50(19):6316-22. PubMed ID: 2205380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt reduction of c-myc expression by antisense RNA inducing terminal differentiation and apoptosis of a human esophageal cancer cell line.
    Zhao X; Wang X; Zhou C; Peng R; Yan S; Wu M
    Sci China B; 1995 May; 38(5):580-9. PubMed ID: 7626199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of changes of N-myc products on the gene expression of heat-shock protein (hsp-70) and nucleolin during differentiation of neuroblastoma cells.
    Murakami T; Ohmori H; Tsuda T; Higashi K
    Prog Clin Biol Res; 1991; 366():65-70. PubMed ID: 2068180
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
    Flickinger KS; Judware R; Lechner R; Carter WG; Culp LA
    Exp Cell Res; 1994 Jul; 213(1):156-63. PubMed ID: 8020586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. dbl oncogene expression in childhood tumors and tumor cell lines.
    Navarro S; Pellín A; Noguera R; Díaz MP; Tsokos M; Triche TJ; Llombart-Bosch A
    Diagn Mol Pathol; 1993 Sep; 2(3):158-62. PubMed ID: 8287229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
    Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E; Da Silva J; Riou G; Bénard I
    Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of phenotypic and molecular characterization for identification of a neuroepithelioma tumor cell line, NUB-20.
    Yeger H; Mor O; Pawlin G; Kaplinsky C; Shiloh Y
    Cancer Res; 1990 May; 50(9):2794-802. PubMed ID: 2158399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.